07 aug: UPDATE: PG&E Second-Quarter Profit Down On San Bruno Pipe..
07 aug: Brazil's CNI: Costs Still Weigh on Productivity, Investm..
07-08-2012 19:05:00

Glencore Says Demand Remains Healthy

Relateret indhold

LONDON--Commodities giant Glencore International PLC (GLEN.LN) said Tuesday that growing euro-zone sovereign debt concerns and the resulting knock to financial market sentiment and commodities prices has tempered the performance of its industrial assets, but that its market operations are still performing well and physical demand remains generally healthy.

Glencore released qualitative statements on its website Tuesday afternoon about its trading and prospects, contained in a second supplementary prospectus statement about its proposed multibillion-dollar merger with miner Xstrata PLC (XTA.LN). The merger would create the world's fourth-largest mining company with a market capitalization of $62 billion, but the two companies are under mounting pressure from some of Xstrata's largest shareholders to sweeten the terms of the deal.

Glencore said it's encouraged by progress in developing growth projects for its industrial assets.

Despite the economic uncertainty, the company said it sees commodity inventories, both on exchanges and within supply chains, as generally low and it continues to see long-term fundamentals for its major commodities as strong.

Earlier Tuesday, Anglo-Swiss miner Xstrata said it remains positive about the medium-term outlook for commodities, but it may slow down some investments as the industry faces a dip in demand and prices in the near term.

Glencore expects to report its half-year results on Aug. 21.

Write to Leia Parker at leia.parker@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

August 07, 2012 13:05 ET (17:05 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Maersk Line-chef tager på charmeoffensiv i Kina

19-09-2014 15:47:03
Den administrerende direktør for Maersk Line, Søren Skou, har besøgt de kinesiske myndigheder i et forsøg på at skaffe opbakning til en ny shipping-alliance med..

Novo/Sydbank: Novo sidder tungt på diabetes-tronen

19-09-2014 12:17:21
Sydbank fastholder sin anbefaling af Novo Nordisk-aktien til trods for, at den amerikanske lægemiddelstyrelse, FDA, torsdag aften har godkendt Novo-konkurrenten..

Novo: Nygodkendt diabetesmiddel giver lynhurtigt effekt

19-09-2014 11:31:02
Novo Nordisks nye kombinationspræparat til behandling af type 2 diabetes, Xultophy, yder allerede efter fire uger en betydelig blodsukkerkontrol.Det fremgår af ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Jyske: Svagt momentum bag lavere kursmål
2
Aktier/åbning: C20 styrer mod rekord efter skotsk afstemning
3
Aktier/middag: Skotterne sender Vestas og C20 til vejrs
4
Novo/Sydbank: Novo sidder tungt på diabetes-tronen
5
Novo: Nygodkendt diabetesmiddel giver lynhurtigt effekt

Relaterede aktiekurser

Glencore PLC ORD USD0.01 359,25 0,4% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. september 2014 09:57:24
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140919.1 - EUROWEB7 - 2014-09-20 09:57:24 - 2014-09-20 09:57:24 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x